Georiga Bancshs Stock Price, News & Analysis

GABA OTC Link

Company Description

Welcome to the overview page for Georiga Bancshs (GABA), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—

0.00%

0.00

Last updated:

-

Performance 1 year

$44.7M

3.0M

Shares outstanding

Latest News

April 10, 2024

0.00%

Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002

clinical trial

March 18, 2024

0.00%

Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders

March 7, 2024

0.00%

Gabather reports initial positive results from the EEG/fMRI target engagement study

SEC Filings

No SEC filings available for Georiga Bancshs.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Georiga Bancshs (GABA)?

The current stock price of Georiga Bancshs (GABA) is $0.0001 as of July 3, 2025.

What is the market cap of Georiga Bancshs (GABA)?

The market cap of Georiga Bancshs (GABA) is approximately 44.7M. Learn more about what market capitalization means .